Showing results (751-760 of 5,598) with videos related to

Sort By:
Pageof 560
International Journal of Clinical Practice|November 21, 2012
Treatment satisfaction with low-dose tamsulosin for symptomatic benign prostatic hyperplasia: results from a multicentre cross-sectional surveyJ H Kim, J Y Park, M M Oh, et al.
International Journal of Clinical Practice|May 22, 2012
A review of family history of cardiovascular disease: risk factor and research toolA Banerjee
International Journal of Clinical Practice|August 20, 2013
Early combination therapy with telmisartan plus amlodipine for rapid achievement of blood pressure goalsS Neldam, B Dahlöf, W Oigman, et al.
International Journal of Clinical Practice|August 20, 2013
Choice of early treatment regimen and impact on β-cell preservation in type 2 diabetesS Mudaliar
International Journal of Clinical Practice|May 14, 2011
It's good to talk! Changes in coronary revascularisation practice in PCI centres without onsite surgical cover and the impact of an angiography video conferencing systemR A Veasey, J A J Hyde, M E Lewis, et al.
International Journal of Clinical Practice|May 14, 2011
Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients - a systematic review and meta-analysisG Trikudanathan, J Israel, J Cappa, et al.
International Journal of Clinical Practice|May 14, 2011
The safety and efficacy of botulinum toxin-A in the management of bladder oversensitivity: a randomised double-blind placebo-controlled trialC Dowson, A Sahai, J Watkins, et al.
International Journal of Clinical Practice|May 14, 2011
Effects of telavancin on coagulation test resultsS L Barriere, M R Goldberg, J W Janc, et al.
International Journal of Clinical Practice|September 29, 2011
The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trialS Al Sifri, A Basiounny, A Echtay, et al.
International Journal of Clinical Practice|October 8, 2011
Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety studyM Nowicki, I Rychlik, H Haller, et al.
Pageof 560